Lane, Heidi A <br/><br/>
Optimal targeting of the mTORC1 kinase in human cancer.  [electronic resource] 

 -  Current opinion in cell biology  Apr 2009 
 - 219-29 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1879-0410 
<br/><br/><label>Standard No.: </label>10.1016/j.ceb.2009.01.016  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Clinical Trials as Topic<br/>Humans<br/>Mechanistic Target of Rapamycin Complex 1<br/>Multiprotein Complexes<br/>Neoplasms--drug therapy<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Protein Kinase Inhibitors--therapeutic use<br/>Proteins<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Signal Transduction--physiology<br/>TOR Serine-Threonine Kinases<br/>Transcription Factors--antagonists & inhibitors